EXECUTIVE CHANGE SUMMARY: Prospex Energy appoints Tom Reynolds as CEO
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News: Read More
| Price | 10.75p on 14-01-2026 at 12:10:05 |
|---|---|
| Change | -1.15p -9.66% |
| Buy | 11.50p |
| Sell | 10.00p |
| Last Trade: | Buy 437.00 at 11.44p |
| Day's Volume: | 109,437 |
| Last Close: | 11.90p |
| Open: | 12.10p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 10.75p - 12.10p |
| 52wk Range: | 5.25p - 12.10p |
| Market Capitalisation: | £660.20m |
| VWAP: | 11.49428p |
| Shares in Issue: | 6.14b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 437 | 11.44p | Ordinary |
10:48:03 - 14-Jan-26 |
| Buy* | 50,000 | 11.44p | Ordinary |
08:16:20 - 14-Jan-26 |
| Unknown* | 50,000 | 11.44p | OTC Trade |
08:16:20 - 14-Jan-26 |
| Buy* | 5,000 | 12.10p | Suspected BUY Trade |
08:00:15 - 14-Jan-26 |
| Buy* | 10,000 | 11.90p | Suspected BUY Trade |
14:00:25 - 13-Jan-26 |
| Buy* | 5 | 11.50p | Ordinary |
13:46:25 - 13-Jan-26 |
| Buy* | 1,225 | 11.275p | Ordinary |
13:12:25 - 13-Jan-26 |
| Buy* | 1 | 11.275p | Ordinary |
12:03:35 - 13-Jan-26 |
| Buy* | 1 | 11.275p | Ordinary |
11:50:43 - 13-Jan-26 |
| Buy* | 9,076 | 11.066p | Ordinary |
11:03:57 - 13-Jan-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Jan 2026 7:00 am | RNS | Notice of 2025 Annual General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 16th Dec 2025 7:00 am | RNS | Grassmuno® marketing authorisation in Germany |
| 12th Dec 2025 7:00 am | RNS | Authority for allotment of New Shares |
| 11th Dec 2025 7:00 am | RNS | Prelim Results and publication of Annual Report |
| 9th Dec 2025 7:00 am | RNS | Primary Safety Endpoint Met in PROTECT trial |
| 6th Nov 2025 7:22 am | RNS | Company to Evaluate Dual Listing on HKEX |
| 30th Oct 2025 7:00 am | RNS | G308 Phase III Year 2 Patient Screening Starts |
| 29th Oct 2025 7:00 am | RNS | Warrant Exercise and Paydown of Debt |